![](/img/cover-not-exists.png)
PSS10 COST PER RESPONDER OF USTEKINUMAB VERSUS ETANERCEPT IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS: ANALYSIS FROM THE ACCEPT TRIAL
SR Feldman, M Augustin, S Martin, P Szapary, B SchenkelVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72713-3
File:
PDF, 70 KB
english, 2010